Ms Anita Maria Sommers, LMFT | |
61 Cottage St, Suite B, Bar Harbor, ME 04609-1860 | |
(760) 815-9952 | |
Not Available |
Full Name | Ms Anita Maria Sommers |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 61 Cottage St, Bar Harbor, Maine |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184914996 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | #MF3340 (Maine) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Anita Maria Sommers, LMFT 32 Pleasant St, Bar Harbor, ME 04609-1632 Ph: (207) 801-2640 | Ms Anita Maria Sommers, LMFT 61 Cottage St, Suite B, Bar Harbor, ME 04609-1860 Ph: (760) 815-9952 |
News Archive
People who develop diabetes and high blood pressure in middle age are more likely to have brain cell loss and other damage to the brain, as well as problems with memory and thinking skills, than people who never have diabetes or high blood pressure or who develop it in old age, according to a new study published in the March 19, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Researchers in Japan have revealed a previously unknown mechanism for pain control involving a newly identified group of cells in the spinal cord, offering a potential target for enhancing the therapeutic effect of drugs for chronic pain.
The twin epidemics of obesity and type 2 diabetes will continue to fuel an explosion in heart failure, already the world's most prevalent chronic cardiovascular disease, according to John McMurray, professor of cardiology at the Western Infirmary, Glasgow, and President of the Heart Failure Association. He reported that around one-third of patients with heart failure have evidence of diabetes, and for them the outlook is very serious. For doctors, he added, effective treatment is "very difficult".
Endologix, developer of minimally invasive treatments for aortic disorders, announced today the presentation of the initial clinical results from the PEVAR Trial at the 2011 iCON annual meeting in Scottsdale, Arizona.
› Verified 7 days ago